Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Gwyn Bebb

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Pulmonary Therapy|June 13, 2023
Symptoms and Experiences with Small Cell Lung Cancer: A Mixed Methods Study of Patients and CaregiversD Gwyn Bebb, Cressida Murray, Andromachi Giannopoulou, et al.
Frontiers in Oncology|August 30, 2024
Development of an algorithm to identify small cell lung cancer patients in claims databasesMark D Danese, Akhila Balasubramanian, D Gwyn Bebb, et al.
American Journal of Clinical Oncology|April 30, 2020
The Population-based Impact of Adjuvant Chemotherapy on Outcomes in T2N0M0 Non-Small Cell Lung CancerRahul K Arora, Amanda W Gibson, D Gwyn Bebb, et al.
BMC Gastroenterology|July 29, 2009
Physical activity and diet behaviour in colorectal cancer patients receiving chemotherapy: associations with quality of lifeLynette E Stephenson, D Gwyn Bebb, Raylene A Reimer, et al.
Translational Oncology|February 10, 2017
ATM-Deficient Colorectal Cancer Cells Are Sensitive to the PARP Inhibitor OlaparibChen Wang, Nicholas Jette, Daniel Moussienko, et al.
Translational Lung Cancer Research|July 18, 2020
The prevalence and prognostic significance of estrogen receptor beta expression in non-small cell lung cancerEmeka K Enwere, Michelle L Dean, Haocheng Li, et al.
American Journal of Clinical Oncology|September 5, 2020
Population-based Treatment Patterns and Outcomes for Stage III Non-Small Cell Lung Cancer Patients: A Real-world Evidence StudyDimas Yusuf, Ryan N Walton, Manjusha Hurry, et al.
Lung Cancer (Amsterdam, Netherlands)|April 17, 2018
Associations of objectively assessed physical activity and sedentary time with health-related quality of life among lung cancer survivors: A quantile regression approachAdrijana D'Silva, Paul A Gardiner, Terry Boyle, et al.
Cell Cycle (Georgetown, Tex.)|May 21, 2014
Low ATM protein expression and depletion of p53 correlates with olaparib sensitivity in gastric cancer cell linesEiji Kubota, Christopher T Williamson, Ruiqiong Ye, et al.
JTO Clinical and Research Reports|September 30, 2021
Retrospective Real-World Outcomes for Patients With <i>ALK</i>-Rearranged Lung Cancer Receiving ALK Receptor Tyrosine Kinase InhibitorsAmanda J W Gibson, Adrian Box, Michelle L Dean, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Pulmonary Therapy|June 13, 2023
Symptoms and Experiences with Small Cell Lung Cancer: A Mixed Methods Study of Patients and CaregiversD Gwyn Bebb, Cressida Murray, Andromachi Giannopoulou, et al.
Frontiers in Oncology|August 30, 2024
Development of an algorithm to identify small cell lung cancer patients in claims databasesMark D Danese, Akhila Balasubramanian, D Gwyn Bebb, et al.
American Journal of Clinical Oncology|April 30, 2020
The Population-based Impact of Adjuvant Chemotherapy on Outcomes in T2N0M0 Non-Small Cell Lung CancerRahul K Arora, Amanda W Gibson, D Gwyn Bebb, et al.
BMC Gastroenterology|July 29, 2009
Physical activity and diet behaviour in colorectal cancer patients receiving chemotherapy: associations with quality of lifeLynette E Stephenson, D Gwyn Bebb, Raylene A Reimer, et al.
Translational Oncology|February 10, 2017
ATM-Deficient Colorectal Cancer Cells Are Sensitive to the PARP Inhibitor OlaparibChen Wang, Nicholas Jette, Daniel Moussienko, et al.
Translational Lung Cancer Research|July 18, 2020
The prevalence and prognostic significance of estrogen receptor beta expression in non-small cell lung cancerEmeka K Enwere, Michelle L Dean, Haocheng Li, et al.
American Journal of Clinical Oncology|September 5, 2020
Population-based Treatment Patterns and Outcomes for Stage III Non-Small Cell Lung Cancer Patients: A Real-world Evidence StudyDimas Yusuf, Ryan N Walton, Manjusha Hurry, et al.
Lung Cancer (Amsterdam, Netherlands)|April 17, 2018
Associations of objectively assessed physical activity and sedentary time with health-related quality of life among lung cancer survivors: A quantile regression approachAdrijana D'Silva, Paul A Gardiner, Terry Boyle, et al.
Cell Cycle (Georgetown, Tex.)|May 21, 2014
Low ATM protein expression and depletion of p53 correlates with olaparib sensitivity in gastric cancer cell linesEiji Kubota, Christopher T Williamson, Ruiqiong Ye, et al.
JTO Clinical and Research Reports|September 30, 2021
Retrospective Real-World Outcomes for Patients With <i>ALK</i>-Rearranged Lung Cancer Receiving ALK Receptor Tyrosine Kinase InhibitorsAmanda J W Gibson, Adrian Box, Michelle L Dean, et al.
Pageof 3